HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adám Remport Selected Research

HLA-B12 antigen

8/2008HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adám Remport Research Topics

Disease

2Chronic Kidney Failure (Chronic Renal Failure)
01/2009 - 01/2008
2Infections
08/2008 - 03/2008
1Cytomegalovirus Infections (Inclusion Disease)
03/2008
1Opportunistic Infections (Opportunistic Infection)
03/2008
1Renal Insufficiency (Renal Failure)
01/2008
1Lymphocele
08/2007

Drug/Important Bio-Agent (IBA)

1CreatinineIBA
01/2009
1HLA-DR6 Antigen (HLA DR6 Antigen)IBA
08/2008
1HLA-DQ3 antigenIBA
08/2008
1HLA-DR11 antigenIBA
08/2008
1HLA-B12 antigenIBA
08/2008
1HLA-A2 Antigen (HLA A2 Antigen)IBA
08/2008
1HLA-C*70 antigenIBA
08/2008
1CytokinesIBA
03/2008
1SolutionsIBA
01/2008
1Prednisone (Sone)FDA LinkGeneric
08/2007
1Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2007
1Sirolimus (Rapamycin)FDA Link
08/2007

Therapy/Procedure

2Transplantation
03/2008 - 08/2007
2Kidney Transplantation
01/2008 - 08/2007
1Therapeutics
03/2008
1Organ Transplantation
03/2008
1Heart Transplantation (Grafting, Heart)
01/2008